Value of Rox Index to Predict Intubation and Intensive Care Unit
Outcome In Patients With Respiratory Failure

Ayshan      Mammadova; Esra      Eriş; Zeynep   Sena   Solmaz; Ayşe   Taşçı   Kara; Aydın      Atasoy; Gül      Gürsel

doi:10.2174/1574887117666220606114549

Abstract

Background: Recent literature suggests that the respiratory rate oxygenation (ROX) index may be useful in predicting intubation indication in hypoxemic patients.

Objective: In this study, we evaluated the accuracy of the ROX index in predicting intubation, length of stay in the ICU, and mortality in ICU patients with hypoxemic respiratory failure with and without hypercapnia.

Methods: A single-centre retrospective cohort study of 290 patients with a preliminary diagnosis of respiratory failure were treated with low-flow oxygen systems. Demographics, medical history, clinical, laboratory, treatment, and prognostic data were obtained from the hospital's electronic records. The ROX index was calculated at the time of ICU admission.

Results: Thirty-seven percent of non-hypercapnic and 69% of hypercapnic patients were intubated (p:0.005). In hypercapnic patients, ROX: 6.9 had highest sensitivity (81%) and specificity (65%) values for intubation (p:0.005). In non-hypercapnic patients, ROX: 6.2 had the highest sensitivity (81%) and specificity (40%) values. While 11% of hypercapnic patients and 30% of non-hypercapnic patients died (p:0.05), 22% of hypercapnic patients and 33% of non-hypercapnic patients stayed in the ICU longer than 14 days (p:0.044). The highest sensitivity and specificity values were found for mortality in hypercapnic patients; for ROX value of 5.94 (sensitivity:86%, specificity:61%) and ICU stay longer than 14 days; for ROX value of 7.4 (sensitivity:71%, specificity:68%).

Conclusion: Results of our study suggest that the ROX index calculated during ICU admission can help predict intubation indication and length of ICU stay in patients with respiratory failure and hypercapnia may influence the cutoff values.

Keywords: ROX index, PaO2/FiO2, respiratory failure, intubation, intensive care unit

« Previous Next »

[1]
Vincent JL, Akça S, De Mendonça A, et al. The epidemiology of acute respiratory failure in critically ill patients(*). Chest  2002; 121(5): 1602-9.
 [http://dx.doi.org/10.1378/chest.121.5.1602] [PMID: 12006450]

[2]
Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA  2016; 315(8): 788-800.
 [http://dx.doi.org/10.1001/jama.2016.0291] [PMID: 26903337]

[3]
Pham T, Rubenfeld GD. Fifty years of research in ARDS the epidemiology of acute respiratory distress syndrome. A 50th birthday review. Am J Respir Crit Care Med  2017; 195(7): 860-70.
 [http://dx.doi.org/10.1164/rccm.201609-1773CP] [PMID: 28157386]

[4]
Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: The Berlin Definition. JAMA  2012; 307(23): 2526-33.
 [PMID: 22797452]

[5]
Roca O, Messika J, Caralt B, et al. Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index. J Crit Care  2016; 35: 200-5.
 [http://dx.doi.org/10.1016/j.jcrc.2016.05.022] [PMID: 27481760]

[6]
Lemiale V, Dumas G, Demoule A, et al. Performance of the ROX index to predict intubation in immunocompromised patients receiving high-flow nasal cannula for acute respiratory failure. Ann Intensive Care  2021; 11(1): 17.
 [http://dx.doi.org/10.1186/s13613-021-00801-z] [PMID: 33501590]

[7]
Roca O, Caralt B, Messika J, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med  2019; 199(11): 1368-76.
 [http://dx.doi.org/10.1164/rccm.201803-0589OC] [PMID: 30576221]

[8]
Rodriguez M, Thille AW, Boissier F, et al. Predictors of successful separation from high-flow nasal oxygen therapy in patients with acute respiratory failure: A retrospective monocenter study. Ann Intensive Care  2019; 9(1): 101.
 [http://dx.doi.org/10.1186/s13613-019-0578-8] [PMID: 31511996]

[9]
Mauri T, Carlesso E, Spinelli E, et al. Increasing support by nasal high flow acutely modifies the ROX index in hypoxemic patients: A physiologic study. J Crit Care  2019; 53: 183-5.
 [http://dx.doi.org/10.1016/j.jcrc.2019.06.020] [PMID: 31254849]

[10]
Gianstefani A, Farina G, Salvatore V, et al. Role of ROX index in the first assessment of COVID-19 patients in the emergency department. Intern Emerg Med  2021; 16(7): 1959-65.
 [http://dx.doi.org/10.1007/s11739-021-02675-2] [PMID: 33646507]

[11]
Duan J, Zeng J, Deng P, et al. High-Flow nasal cannula for COVID-19 patients: A multicenter retrospective study in china. Front Mol Biosci  2021; 8: 639100.
 [http://dx.doi.org/10.3389/fmolb.2021.639100] [PMID: 33928119]

[12]
Chandel A, Patolia S, Brown AW, et al. High-Flow nasal cannula therapy in COVID-19: Using the ROX index to predict success. Respir Care  2021; 66(6): 909-19.
 [http://dx.doi.org/10.4187/respcare.08631] [PMID: 33328179]

[13]
Panadero C, Abad-Fernández A, Rio-Ramirez MT, et al. High-flow nasal cannula for acute respiratory distress syndrome (ARDS) due to COVID-19. Multidiscip Respir Med  2020; 15(1): 693.
 [http://dx.doi.org/10.4081/mrm.2020.693] [PMID: 32983456]

[14]
Artacho Ruiz R, Artacho Jurado B, Caballero Güeto F, et al. Predictors of success of high-flow nasal cannula in the treatment of acute hypoxemic respiratory failure. Med Intensiva  2021; 45(2): 80-7.
 [http://dx.doi.org/10.1016/j.medine.2019.07.008] [PMID: 31455561]

[15]
Lee CU, Jo YH, Lee JH, et al. The index of oxygenation to respiratory rate as a prognostic factor for mortality in Sepsis. Am J Emerg Med  2021; 45: 426-32.
 [http://dx.doi.org/10.1016/j.ajem.2020.09.052] [PMID: 33039213]

[16]
Cornillon A, Balbo J, Coffinet J, et al. The ROX index as a predictor of standard oxygen therapy outcomes in thoracic trauma. Scand J Trauma Resusc Emerg Med  2021; 29(1): 81.
 [http://dx.doi.org/10.1186/s13049-021-00876-4] [PMID: 34154631]

[17]
Zaboli A, Ausserhofer D, Pfeifer N, et al. The ROX index can be a useful tool for the triage evaluation of COVID-19 patients with dyspnoea. J Adv Nurs  2021; 77(8): 3361-9.
 [http://dx.doi.org/10.1111/jan.14848] [PMID: 33792953]

[18]
Cable C, Kashiouris M, Gross A, Wiese B. Utility of the respiratory rate-oxygenation (Rox) index in predicting respiratory failure requiring mechanical ventilation in acute care medicine. Chest  2020; 158(4): A576.
 [http://dx.doi.org/10.1016/j.chest.2020.08.544]

[19]
Suliman LA, Abdelgawad TT, Farrag NS, Abdelwahab HW. Validity of ROX index in prediction of risk of intubation in patients with COVID-19 pneumonia. Adv Respir Med  2021; 89(1): 1-7.
 [http://dx.doi.org/10.5603/ARM.a2020.0176] [PMID: 33471350]

[20]
Wettstein RB, Shelledy DC, Peters JI. Delivered oxygen concentrations using low-flow and high-flow nasal cannulas. Respir Care  2005; 50(5): 604-9.
 [PMID: 15871753]

Rights & Permissions Print Cite

Article Metrics

3

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/1574887117666220606114549	Print ISSN 1574-8871
Publisher Name Bentham Science Publisher	Online ISSN 1876-1038

Reviews on Recent Clinical Trials

Value of Rox Index to Predict Intubation and Intensive Care Unit Outcome In Patients With Respiratory Failure

Abstract Play Pause

Related Journals

Abstract